Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and people. This functions as a prodrug, meaning it’s https://apo-lisdexamfetamine-in-992974.verybigblog.com/42267939/lisdexamfetamine-in-canada-a-detailed-overview